TSE:MFC

Manulife Financial (MFC.TO)

60.29
-0.38 (0.63%)
as of Jul 23, 2026, 5:23:07 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has received mixed reviews from various experts, highlighting both its strengths and concerns. Many praise the company for its solid performance in Asia and wealth management, coupled with a healthy dividend yield, making it an attractive income stock. However, some analysts express caution due to overvaluation, suggesting that MFC may be overbought, trading at over 2x book value with slow earnings growth of around 8-9%. While the stock is seen as a reasonable long-term holding, there are calls for potential buying opportunities during market pullbacks. The general sentiment reflects a wait-and-see approach given the mixed indicators and the overall health of the financial sector.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY

MFC vs. SLF Equally good. Prefers MFC for the great Asian franchise, which has a lot of opportunity. Has also built a great asset management business that has continued to do well. MFC has a great growth profile at a cheaper multiple. MFC gets the nod, but you can own both. They're great businesses that will continue to pay a good dividend for many years.

BUY

He continues to try to look at the big picture. It is cheaper than SLF-T with potentially more horsepower in terms of growth and it has a higher dividend yield. The opportunity in MFC-T comes from management. Changes they make do not come overnight. The recent drop is a buying opportunity.

DON'T BUY

The reason it went down after the blowout earnings is related to the financial crisis. During the crisis, MFC almost went out of business. They totally de-risked themselves coming out of the crisis. They never benefitted from good times. The best thing for insurance companies is for interest rates go up. Prefers Sunlife, a much better company.

TOP PICK
Expecting good numbers from all the lifecos. Extremely well capitalized. Asian operations doing extremely well. Should see dividend increases and capital appreciation. Inexpensive relative to peers. Yield is 4.26%. (Analysts’ price target is $28.10)
HOLD
Their performance was not that good recently but they have decent valuation, good growth and good positioning. Financials have lagged a little recently. He thinks it is incredibly cheap here. Stick to your guns.
DON'T BUY
Could easily be over $30, or not. Long-term performance has been ugly since the financial crisis. Lack of growth, hard to understand the valuation. Interest rates rising could be a tailwind. Hard to evaluate the business quality.
WEAK BUY
It has trouble breaking $28, but he remains positive on this long term and bought shares in the low-20s. Managers are doing a good job. MFC won't be exciting, but their over 4% dividend probably will grow. Happy to own it.
BUY
When companies break down, it takes 10 years to repair the damage. A lot of investors suffer exhaustion. But this creates an opportunity for the next expansionary cycle. The whole insurance sector is attractive. Knocking on the door of making a 12-year high. Great global footprint, Chinese business, wealth management, growing earnings, nice dividend. If it trades through $28, you're going to have a pretty good ongoing rally, and this is likely with the group's tailwinds.
BUY
A core holding of his. It pays a 4% yield with strong growth in Asia. New management in recent years has reduced legacy costs holding this back. He sees good growth for MFC and is trading at a modest 9x earning this year. In 2008, they were heavily exposed to equity markets, but a lot of this is now behind them. People are unforgiving of large financials cutting their dividend, but MFC's dividend has been catching up, which he's glad to see.
BUY
People were worried about low interest rates and asset write downs. These haven't happened. Diversified business model. Environment is very strong for them, especially in Asia. Expects dividend increases. Not an expensive price to book value.
BUY

MFC vs. SLF With increasing interest rates, either makes a lot of sense right now. He owns SLF. With MFC, you get about twice the exposure to the Asian market. SLF has more exposure to Canada. MFC has more beta, higher dividend, a bit cheaper. With the Asian recovery, MFC could perform a bit better. SLF gives you more stability. SLF yield is 3.5%. MFC yield is 4.5%

BUY
They are participating in the positive sentiment on reopening. There is still upside to this whole group. She thinks this one will continue to trade higher with the broader group.
BUY
An attractive choice right now. They are starting to get over their legacy business and are trying to sell it. They have had a few good quarters. Their book value is growing since it will garner a higher valuation. Return on equity will start to improve with higher earnings. Likes their Asian presence.
BUY
Strong Asian business. If we see a couple of quarters with traction, pretty conceivable to see a 3-handle on the stock. Management doing a good job cleaning up US legacy businesses. Wealth management doing quite well. Price doesn't reflect full value of the company.
PAST TOP PICK
(A Top Pick Jan 30/20, Down 4%) They have been so desperate for a steepening yield curve. Stocks have already started to respond to this. Buying this with a dividend of 4%+ dividend yield. They are poised to rebound.
Showing 256 to 270 of 2,283 entries